Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study

BACKGROUND: Six months of oxaliplatin-based chemotherapy is the standard adjuvant chemotherapy for completely resected stage III colorectal cancer (CRC). Also, patients with stage II CRC who are considered to be at high risk of disease recurrence often receive the same adjuvant chemotherapy treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuruta, Atsushi, Yamashita, Kazuki, Tanioka, Hiroaki, Tsuji, Akihito, Inukai, Michio, Yamakawa, Toshiki, Yamatsuji, Tomoki, Yoshimitsu, Masanori, Toyota, Kazuhiro, Yamano, Taketoshi, Nagasaka, Takeshi, Okajima, Masazumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125792/
https://www.ncbi.nlm.nih.gov/pubmed/27920498
http://dx.doi.org/10.2147/DDDT.S112322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125792/
https://www.ncbi.nlm.nih.gov/pubmed/27920498
http://dx.doi.org/10.2147/DDDT.S112322

Ejemplares similares